|
ViennaLab,
founded 1990, develops and manufactures products for medical in-vitro
diagnostics
in the field of genetic diseases and predispositions.
The current focus is
on cardiovascular diseases and inherited disorders of
iron metabolism (haemochromatosis). The range of products also includes
Thalassemia,
Familial Mediterranean Fever
(FMF), Gaucher Disease, Alzheimer and Pharmacogenetics.
ViennaLab´s
goals are
to identify promising diagnostic tests at an
early stage, perform product development efficiently using proven
expertise
and experience, and market novel products internationally in close
collaboration
with highly committed distributing partners.
External proposals
for research projects (epidemiology,
identification of phenotype-related SNPs) and / or assay
development are welcome and will be carefully discussed and evaluated
regarding
their feasibility and market potential.
| ViennaLab is currently conducting an international survey on genetic
testing of iron overload (haemochromatosis).
To participate, please go to "links". |
In 2001,
ViennaLab and Hoffmann-La Roche signed an Agreement granting ViennaLab
worldwide, non-exclusive rights to manufacture and sell PCR-based
diagnostic
tests.
|
|
|
|